said its revenue soared 82% to RM1.18bil in the second quarter boosted by sales of Sinovac Covid-19 vaccine to the government.
"The Group has submitted approval for the vaccine to be used for the adolescent population in Malaysia to NPRA and upon approval, it will create a demand for 6 million doses," it said. Meanwhile, a new study in China suggested that a third shot of the Sinovac vaccine administered six months or more after the second dose will boost immunity against the deadly virus.
Then please donate medical supplies, vaccines and medicine to people not raking profit only
Game of monopoly .
Nice. Some get sick and die, some makes billions. Wonder who share this wealth.
It’s pandemic, and some make money out it!
How many Malaysians died waiting for their vaccines to be rebottled ? To help local firms